Quick Takeaways
- ORBIMED CAPITAL LLC filed SCHEDULE 13G/A for SI-BONE, Inc. Common Stock, par value $0.0001 per share (SIBN).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2025.
ORBIMED CAPITAL LLC - 31 Dec 2025 SCHEDULE 13G/A Report for SI-BONE, Inc. Common Stock, par value $0.0001 per share (SIBN)
- Filing Manager
- ORBIMED CAPITAL LLC
- Reporting Manager
- OrbiMed Capital LLC
- Symbol
- SIBN
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 18:30:45 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED CAPITAL LLC disclosed 0% ownership in SI-BONE, Inc. Common Stock, par value $0.0001 per share (SIBN) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 17 Feb 2026, 18:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| OrbiMed Capital LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon / Member | |
| OrbiMed Advisors LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon / Member |